NCT03860532View on ClinicalTrials.gov

Phase I Clinical Trial in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

HMPL-011 tablets

Eligible subjects will recieve 1200 mg HMPL-011 tablets under fed and diet circumstance.

DRUG

HMPL-011 capsules

Eligible subjects will recieve 1200 mg HMPL-011 capsules under fed and diet circumstance.

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT03860532 - Phase I Clinical Trial in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter